The Report Migraine
Global Clinical Trials Review, H1, 2016 provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
GlobalData's clinical trial
report, Migraine
Global Clinical Trials Review, H1, 2016"
provides an overview of Migraine clinical trials scenario. This
report provides top line data relating to the clinical trials on
Migraine. Report includes an overview of trial numbers and their
average enrollment in top countries conducted across the globe. The
report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor
type. Report also provides prominent drugs for in-progress trials
(based on number of ongoing trials). GlobalData Clinical Trial
Reports are generated using GlobalDatas proprietary database - Pharma
eTrack Clinical trials database. Clinical trials are collated from
80+ different clinical trial registries, conferences, journals, news
etc across the globe. Clinical trials database undergoes periodic
update by dynamic process.
The report enhances the
decision making capabilities and helps to create an effective counter
strategies to gain competitive advantage.
Download Sample copy of this
Report at:
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key
business strategies with regards to investment
- Helps in identifying
prominent locations for conducting clinical trials which saves time
and cost
- Provides top level analysis
of Global Clinical Trials Market which helps in identifying key
business opportunities
- Supports understanding of
trials count and enrollment trends by country in global therapeutics
market
- Aids in interpreting the
success rates of clinical trials by providing a comparative scenario
of completed and uncompleted (terminated, suspended or withdrawn)
trials
- Facilitates clinical trial
assessment of the indication on a global, regional and country level
Browse Our Press Releases by
Prnewswire:
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing
to Clinical Trials in Europe 11
Top Countries Contributing to
Clinical Trials in North America 12
Top Countries Contributing to
Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing
to Clinical Trials in Central and South America 14
Clinical Trials by G7
Countries: Proportion of Migraine to Central Nervous System Clinical
Trials 15
Clinical Trials by Phase in G7
Countries 16
Clinical Trials in G7 Countries
by Trial Status 17
Clinical Trials by E7
Countries: Proportion of Migraine to Central Nervous System Clinical
Trials 18
Clinical Trials by Phase in E7
Countries 19
Clinical Trials in E7 Countries
by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status
23
Clinical Trials by End Point
Status 24
Subjects Recruited Over a
Period of Time 25
Clinical Trials by Sponsor Type
26
Prominent Sponsors 27
Top Companies Participating in
Migraine Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on
Migraine 31
Mar 28, 2016: Alder Reports
Phase 2b Trial of ALD403 Meets Primary and Secondary Endpoints
Demonstrating Migraine Prevention in Patients with Chronic Migraine
31
Mar 01, 2016: CoLucid
Pharmaceuticals Announces Special Protocol Agreement for SPARTAN 32
Feb 23, 2016: CoLucid
Pharmaceuticals Announces Confirmatory Support for
Non-vasoconstrictive Mechanism of Action for Lasmiditan 32
Clinical Trial Profile
Snapshots 34
Appendix 517
Abbreviations 517
Definitions 517
Research Methodology 518
Secondary Research 518
About GlobalData 519
Contact Us 519
Disclaimer 519
Source 520
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment